NEW YORK (GenomeWeb) – QFAB Bioinformatics said this week that it has been selected by Australia's Garvan Institute of Medical Research to provide whole genome sequence analysis services to researchers in Australia and the Asia-Pacific region.
According to the QFAB, the partnership will provide researchers in the scientific and medical community with high-throughput sequencing and analysis services that span experimental design through to variant interpretation. This agreement extends a long-term relationship between the Garvan Institute and QFAB and "offers strong support for our business," Jeremy Barker, QFAB's CEO, said in a statement.
Financial and other terms of the agreement were not disclosed.